top of page
NIH Director Francis Collins Resigns
Monday
FDA Approves Mirdametinib for NF1
Saturday
NIH Cuts 'Indirect Costs' Funding - 15% Cap
Monday
Itovebi Approved for Metastatic Breast Cancer
Monday
FDA Approves Novartis' Kisqali for Breast Cancer
Wednesday
NIH Director Francis Collins Resigns
Monday
bottom of page